Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

ImmunoGen, Inc. Announces Presentation of Favorable SAR3419 Interim Clinical Data at ASCO
Yahoo/BusinessWire
Saturday, June 4, 2011 - 10:03am
tags:
Immunogen, SAR3419, non-Hodgkin's lymphoma
Medivation and Astellas Announce New Study Results Confirming Clinical Effects and Tolerability of MDV3100 in Advanced Prostate Cancer
Yahoo/MarketWire
Saturday, June 4, 2011 - 10:01am
tags:
Medivation, Astellas, MDV3100, prostate cancer
EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients
Yahoo/PR NewsWire
Saturday, June 4, 2011 - 9:57am
tags:
EntreMed, ENMD-2076, ovarian cancer
Orexigen puts obesity drug development on hold
Yahoo/AP
Saturday, June 4, 2011 - 9:51am
tags:
Orexigen, obesity, weight loss, Contrave
J&J Must Pay $327 Million Over Deceptive-Marketing Claims
Bloomberg
Friday, June 3, 2011 - 6:51pm
tags:
JNJ, settlements, Risperdal, antipsychotics, Ortho-McNeil-Janssen
Rx For Amgen: Issue Dividend
Motley Fool
Friday, June 3, 2011 - 6:49pm
tags:
dividends, Amgen
Big-Pharma Drugs to Dominate Cancer Event
Barron's
Friday, June 3, 2011 - 6:48pm
tags:
ASCO, cancer, Pfizer, Roche, Bristol-Myers Squibb, Eli Lilly, Merck, Ariad Pharmaceuticals, Novartis
Forest Labs speeds up stock repurchase plan
Yahoo/AP
Friday, June 3, 2011 - 11:36am
tags:
stock buyback, Forest Labs
A Fight Is Brewing Over Generic Viagra
Barron's
Friday, June 3, 2011 - 11:33am
tags:
generics, Viagra, Watson Pharmaceuticals, Pfizer
Endo Pharmaceuticals sued by sales reps
Reuters
Friday, June 3, 2011 - 10:50am
tags:
Endo, drug reps, overtime lawsuits
Impax Laboratories Confirms Patent Suit Relating To Generic Detrol® Immediate-Release 1 Mg And 2 Mg Tablets
TheStreet.com
Friday, June 3, 2011 - 10:49am
tags:
patents, Impax, Detrol, Pfizer
7 Dirt-Cheap Takeover Targets in Biotech
Seeking Alpha
Friday, June 3, 2011 - 10:44am
tags:
M&A, Acorda Therapeutics, Antares, Alnylam, BioSante, Catalyst, Inhibitex, Keryx
Roche’s Tarceva Stalls Lung Cancer in Late-Stage Study
Yahoo/AP
Friday, June 3, 2011 - 10:42am
tags:
Roche, Tarceva, lung cancer
Pharmasset rises as analyst says hepatitis C drug could be approved in 2014, raises target
Yahoo/AP
Friday, June 3, 2011 - 10:40am
tags:
Pharmasset, hepatitis C
Orexigen puts US obesity drug development on hold, cites FDA demands, shares skid in premarket
Yahoo/AP
Friday, June 3, 2011 - 9:19am
tags:
FDA, Orexigen, obesity, Contrave
New GSK lung drug hits most targets in two studies
Yahoo/Reuters
Friday, June 3, 2011 - 9:18am
tags:
GSK, Relovair, Theravance, COPD
A New Pricing Game for Drugmakers in Europe
Bloomberg Businessweek
Friday, June 3, 2011 - 9:16am
tags:
drug pricing, Europe
Pharma Needs an Innovation Intervention
Businessweek
Thursday, June 2, 2011 - 11:35pm
tags:
innovation, patents
Johnson & Johnson Hid Antibiotic Levaquin Risk, Lawyer Says
Bloomberg
Thursday, June 2, 2011 - 11:32pm
tags:
Levaquin, antibiotics, JNJ
Blood Pressure Drugs Do Not Raise Cancer Risk
Pharmalot
Thursday, June 2, 2011 - 11:31pm
tags:
antihypertensives, cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.